Amgen Inc.

Amgen is a U.S. biotechnology company that researches, develops, manufactures and commercializes medicines for serious diseases. Its discovery and development work includes biologic medicines, antibodies, other protein-based approaches and selected targeted therapeutics. The company operates across oncology, inflammatory disease, cardiovascular and metabolic disorders, and rare conditions. Headquartered in Thousand Oaks, California, Amgen is listed on Nasdaq. Its integrated capabilities extend from molecular research and translational development to manufacturing and medicine supply. Amgen combines in-house scientific platforms with external research collaborations to pursue treatment approaches in disease areas where substantial patient needs remain.